A prospective natural history study of coronary atherosclerosis using fractional flow reserve

Autor: Gabor G. Toth, Emanuele Barbato, Nick Curzen, Bernard De Bruyne, Nico H.J. Pijls, William F. Fearon, Gilles Rioufol, Zsolt Piroth, Pim A.L. Tonino, Peter Jüni, Nils P. Johnson
Přispěvatelé: Cardiovascular Biomechanics, Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), Barbato, Emanuele, Toth, Gg, Johnson, Np, Pijls, Nhj, Fearon, Wf, Tonino, Pal, Curzen, N, Piroth, Z, Rioufol, G, Juni, P, De Bruyne, B.
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
medicine.medical_specialty
stable angina
Percutaneous
Time Factors
[SDV]Life Sciences [q-bio]
clinical outcome
Fractional flow reserve
Coronary Artery Disease
030204 cardiovascular system & hematology
Coronary Angiography
Severity of Illness Index
vessel related
Coronary artery disease
03 medical and health sciences
0302 clinical medicine
Percutaneous Coronary Intervention
Internal medicine
medicine
Humans
030212 general & internal medicine
Prospective Studies
cardiovascular diseases
fractional flow reserve
Coronary atherosclerosis
business.industry
Middle Aged
medicine.disease
Atherosclerosis
Prognosis
Coronary Vessels
3. Good health
Surgery
Fractional Flow Reserve
Myocardial

Stenosis
Conventional PCI
Cardiology
Female
Cardiology and Cardiovascular Medicine
business
Mace
Natural history study
Follow-Up Studies
Zdroj: Journal of the American College of Cardiology, 68(21), 2247-2255. Elsevier
Journal of the American College of Cardiology
Journal of the American College of Cardiology, Elsevier, 2016, 68 (21), pp.2247-2255. ⟨10.1016/j.jacc.2016.08.055⟩
ISSN: 0735-1097
Popis: International audience; BACKGROUND: In patients with coronary artery disease, clinical outcome depends on the extent of reversible myocardial ischemia. Whether the outcome also depends on the severity of the stenosis as determined by fractional flow reserve (FFR) remains unknown. OBJECTIVES: This study sought to investigate the relationship between FFR values and vessel-related clinical outcome. METHODS: We prospectively studied major adverse cardiovascular events (MACE) at 2 years in 607 patients in whom all stenoses were assessed by FFR and who were treated with medical therapy alone. The relationship between FFR and 2-year MACE was assessed as a continuous function. Logistic and Cox proportional hazards regression models were used to calculate the average decrease in the risk of MACE per 0.05-U increase in FFR. RESULTS: MACE occurred in 272 (26.5%) of 1,029 lesions. Target lesions with diameter stenosis \textgreater/=70% were more often present in the MACE group (p \textless 0.01). Median FFR was significantly lower in the MACE group versus the non-MACE group (0.68 [interquartile range: 0.54 to 0.77] vs. 0.80 [interquartile range: 0.70 to 0.88]; p \textless 0.01). The cumulative incidence of MACE significantly increased with increasing FFR quartiles. An average decrease in MACE per 0.05-unit increase in FFR was statistically significant even after adjustment for all clinical and angiographic features (odds ratio: 0.81; 95% confidence interval: 0.76 to 0.86]). The strongest increase in MACE occurred for FFR values between 0.80 and 0.60. In multivariable Cox regression analysis, FFR was significantly associated with MACE up to 2 years (hazard ratio: 0.87; 95% confidence interval: 0.83 to 0.91]). CONCLUSIONS: In patients with stable coronary disease, stenosis severity as assessed by FFR is a major and independent predictor of lesion-related outcome. (FAME II - Fractional Flow Reserve [FFR] Guided Percutaneous Coronary Intervention [PCI] Plus Optimal Medical Treatment [OMT] Verses OMT; NCT01132495).
Databáze: OpenAIRE